Not an eMediNexus Member?
London: Oxford University has stated it would study if adalimumab, a type of anti-inflammatory known as an anti-tumour necrosis ...MORE
Biologics used for the treatment of psoriasis may also help reduce lipid-rich necrotic core (LRNC), a high-risk plaque associate ...MORE
Polycystic ovarian syndrome (PCOS) was found to be associated with about a two-fold risk of developing psoriasis in a propensity ...MORE
Patients with rheumatoid arthritis (RA) had no increased risk for developing type 2 diabetes, reported a large population-based ...MORE
Administration of once-daily topical roflumilast improved the signs and symptoms of chronic plaque psoriasis, including the lesi ...MORE
Results from two late-breaking phase 3 trials of the investigational interleukin-17A and IL-17F inhibitor bimekizumab have revea ...MORE